Susquehanna International Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Sell |
52,334
-8,523
| -14% | -$345K | ﹤0.01% | 2214 |
|
|
2025
Q1 | $3.13M | Sell |
60,857
-3,266
| -5% | -$168K | ﹤0.01% | 1727 |
|
|
2024
Q4 | $3.55M | Buy |
64,123
+51,669
| +415% | +$2.86M | ﹤0.01% | 1356 |
|
|
2024
Q3 | $410K | Buy |
+12,454
| New | +$410K | ﹤0.01% | 3920 |
|
|
2024
Q2 | – | Sell |
-60,994
| Closed | -$2.22M | – | 6568 |
|
|
2024
Q1 | $2.22M | Sell |
60,994
-30,429
| -33% | -$1.11M | ﹤0.01% | 1689 |
|
|
2023
Q4 | $1.85M | Buy |
+91,423
| New | +$1.85M | ﹤0.01% | 2031 |
|
|
2023
Q3 | – | Sell |
-32,435
| Closed | -$586K | – | 6336 |
|
|
2023
Q2 | $586K | Buy |
+32,435
| New | +$586K | ﹤0.01% | 3412 |
|
|
2022
Q4 | – | Sell |
-14,257
| Closed | -$244K | – | 6713 |
|
|
2022
Q3 | $244K | Buy |
+14,257
| New | +$244K | ﹤0.01% | 4511 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6639 |
|